1. Home
  2. IMMP vs TRVG Comparison

IMMP vs TRVG Comparison

Compare IMMP & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • TRVG
  • Stock Information
  • Founded
  • IMMP 1987
  • TRVG 2005
  • Country
  • IMMP Australia
  • TRVG Germany
  • Employees
  • IMMP N/A
  • TRVG N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • TRVG EDP Services
  • Sector
  • IMMP Health Care
  • TRVG Technology
  • Exchange
  • IMMP Nasdaq
  • TRVG Nasdaq
  • Market Cap
  • IMMP 251.8M
  • TRVG 278.1M
  • IPO Year
  • IMMP N/A
  • TRVG N/A
  • Fundamental
  • Price
  • IMMP $1.76
  • TRVG $3.24
  • Analyst Decision
  • IMMP Buy
  • TRVG Buy
  • Analyst Count
  • IMMP 1
  • TRVG 4
  • Target Price
  • IMMP $7.00
  • TRVG $4.50
  • AVG Volume (30 Days)
  • IMMP 79.3K
  • TRVG 113.3K
  • Earning Date
  • IMMP 10-21-2025
  • TRVG 08-05-2025
  • Dividend Yield
  • IMMP N/A
  • TRVG N/A
  • EPS Growth
  • IMMP N/A
  • TRVG N/A
  • EPS
  • IMMP N/A
  • TRVG N/A
  • Revenue
  • IMMP $3,019,249.00
  • TRVG $592,176,160.00
  • Revenue This Year
  • IMMP $50.37
  • TRVG $17.31
  • Revenue Next Year
  • IMMP N/A
  • TRVG $10.27
  • P/E Ratio
  • IMMP N/A
  • TRVG N/A
  • Revenue Growth
  • IMMP 24.11
  • TRVG 7.39
  • 52 Week Low
  • IMMP $1.32
  • TRVG $1.60
  • 52 Week High
  • IMMP $2.72
  • TRVG $5.83
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 52.82
  • TRVG 39.01
  • Support Level
  • IMMP $1.63
  • TRVG $3.15
  • Resistance Level
  • IMMP $1.85
  • TRVG $3.89
  • Average True Range (ATR)
  • IMMP 0.07
  • TRVG 0.25
  • MACD
  • IMMP -0.01
  • TRVG -0.05
  • Stochastic Oscillator
  • IMMP 52.08
  • TRVG 5.88

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and All other countries.

Share on Social Networks: